APA (7th ed.) Citation

TJ, H., TJ, F., D, Z., JE, J., MA, P., KK, T., . . . MS, B. (2026). Accuracy of Index Lymph Node Pathology in Predicting Overall Response to Neoadjuvant Immunotherapy for Clinical Stage III Melanoma: Results From the Prospective NeoACTIVATE Arm C (NCT03554083) Substudy. Annals of surgical oncology, 33(8), 7471. https://doi.org/10.1245/s10434-026-19899-1

Chicago Style (17th ed.) Citation

TJ, Hieken, et al. "Accuracy of Index Lymph Node Pathology in Predicting Overall Response to Neoadjuvant Immunotherapy for Clinical Stage III Melanoma: Results From the Prospective NeoACTIVATE Arm C (NCT03554083) Substudy." Annals of Surgical Oncology 33, no. 8 (2026): 7471. https://doi.org/10.1245/s10434-026-19899-1.

MLA (9th ed.) Citation

TJ, Hieken, et al. "Accuracy of Index Lymph Node Pathology in Predicting Overall Response to Neoadjuvant Immunotherapy for Clinical Stage III Melanoma: Results From the Prospective NeoACTIVATE Arm C (NCT03554083) Substudy." Annals of Surgical Oncology, vol. 33, no. 8, 2026, p. 7471, https://doi.org/10.1245/s10434-026-19899-1.